HeartBeam, Inc.·4

Mar 23, 5:36 PM ET

Vajdic Branislav 4

Research Summary

AI-generated summary

Updated

HeartBeam (BEAT) President Vajdic Receives Option Award

What Happened Branislav Vajdic, President and a director of HeartBeam, was granted a derivative award of options covering 61,932 shares of common stock on February 9, 2026. The Form 4 records the acquisition value as $0.00 (this is an option grant, not an open‑market purchase). The options were issued under the Company’s 2022 Equity Incentive Plan.

Key Details

  • Transaction date: February 9, 2026; filing date: March 23, 2026 (filed late relative to the trade date).
  • Transaction type: Award/Grant (derivative); Form shows $0.00 per share (no immediate cash outlay).
  • Shares/options granted: 61,932 options.
  • Vesting: Half (30,966 options) vest on March 31, 2026 (three-month anniversary from the Jan 1, 2026 vesting commencement date) and the remaining 30,966 vest on June 30, 2026 (six-month anniversary). (See footnote F1.)
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Plan: Options issued from the Company’s 2022 Equity Incentive Plan.
  • Timeliness: The Form 4 was filed on 2026-03-23 for a 2026-02-09 grant — the filing appears late (marked L in timeliness conventions), which is an SEC reporting issue but does not by itself indicate trading intent.

Context This was a grant of stock options (a compensation award), not an immediate purchase of shares. Options do not equal owned common stock until exercised and vesting conditions are met; here the award vests in two tranches in March and June 2026. Such grants are common for executive compensation and are informational rather than a direct bullish/sell signal.